{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:49:36Z","timestamp":1790682576014,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jocn.2017.10.041","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T08:01:41Z","timestamp":1509955301000},"page":"285-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study"],"prefix":"10.1016","volume":"47","author":[{"given":"Sandi","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Wen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2017.10.041_b0005","first-page":"45","article-title":"Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis","volume":"34","author":"Albert","year":"1994","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2017.10.041_b0010","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.2003.05.063","article-title":"Cost of migration: invasion of malignant gliomas and implications for treatment","volume":"21","author":"Giese","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0025-6196(12)65470-6","article-title":"Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms","volume":"62","author":"Kelly","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jocn.2017.10.041_b0020","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/1097-0142(20011215)92:12<3155::AID-CNCR10158>3.0.CO;2-C","article-title":"Population-based epidemiologic data on brain tumors in German children","volume":"92","author":"Kaatsch","year":"2001","journal-title":"Cancer"},{"issue":"15 Suppl 2:ii","key":"10.1016\/j.jocn.2017.10.041_b0025","first-page":"1","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010","author":"Ostrom","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0030","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s00381-012-1890-x","article-title":"Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome","volume":"28","author":"Das","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jocn.2017.10.041_b0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3171\/foc.2003.14.2.2","article-title":"Pediatric supratentorial high-grade gliomas","volume":"14","author":"Tamber","year":"2003","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.jocn.2017.10.041_b0040","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ijrobp.2010.03.013","article-title":"Glioblastoma in children: a single-institution experience","volume":"80","author":"Perkins","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jocn.2017.10.041_b0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3171\/2010.5.PEDS09558","article-title":"Long-term outcomes in children with glioblastoma","volume":"6","author":"Song","year":"2010","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.jocn.2017.10.041_b0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3892\/ijo.2013.1770","article-title":"Extent of resection and radiotherapy in GBM: a 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients","volume":"42","author":"Zinn","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0055","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","article-title":"Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease","volume":"28","author":"Paugh","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jocn.2017.10.041_b0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocn.2017.10.041_b0070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocn.2017.10.041_b0075","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/neuonc\/nor092","article-title":"Treatment of high-grade glioma in children and adolescents","volume":"13","author":"MacDonald","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0080","first-page":"7404","article-title":"Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort","volume":"61","author":"Pollack","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocn.2017.10.041_b0085","first-page":"418","article-title":"Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort","volume":"105","author":"Pollack","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2017.10.041_b0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/neuonc\/noq191","article-title":"Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0095","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2009.26.8789","article-title":"Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a pediatric brain tumor consortium study","volume":"28","author":"Gururangan","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0100","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/neuonc\/noq033","article-title":"Bevacizumab in recurrent high-grade pediatric gliomas","volume":"12","author":"Narayana","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0105","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/pbc.21272","article-title":"High-grade astrocytoma in very young children","volume":"49","author":"Sanders","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jocn.2017.10.041_b0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.wneu.2012.09.015","article-title":"Gross total resection correlates with long-term survival in pediatric patients with glioblastoma","volume":"79","author":"Yang","year":"2013","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jocn.2017.10.041_b0115","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1158\/1078-0432.CCR-07-1016","article-title":"Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report","volume":"13","author":"Broniscer","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jocn.2017.10.041_b0120","doi-asserted-by":"crossref","first-page":"E727","DOI":"10.1097\/BRS.0b013e31824584c0","article-title":"Prognostic factors and survival in primary malignant astrocytomas of the spinal cord: a population-based analysis from 1973 to 2007","volume":"37","author":"Adams","year":"2012","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.jocn.2017.10.041_b0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000353135","article-title":"Analysis of risk factors and survival in pediatric high-grade spinal cord astrocytoma: a population-based study","volume":"48","author":"Lam","year":"2012","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.jocn.2017.10.041_b0130","unstructured":"NIH. SEER Cause of death recode. In: Surveillance Research Program NCI, editor; 2014."},{"key":"10.1016\/j.jocn.2017.10.041_b0135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","article-title":"Survival analysis part I: basic concepts and first analyses","volume":"89","author":"Clark","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jocn.2017.10.041_b0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11060-013-1251-y","article-title":"Risk factors and long-term survival in adult patients with primary malignant spinal cord astrocytomas","volume":"115","author":"Wong","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0145","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00381-008-0780-8","article-title":"Glioblastoma multiforme in children: experience at Hospital Infantil de Mexico Federico Gomez","volume":"25","author":"Sanchez-Herrera","year":"2009","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jocn.2017.10.041_b0150","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.3747\/co.v18i1.675","article-title":"The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian paediatric brain tumour consortium","volume":"18","author":"Bartels","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jocn.2017.10.041_b0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006123-199602000-00006","article-title":"High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis","volume":"38","author":"Campbell","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2017.10.041_b0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1215\/S1152851703000620","article-title":"Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis","volume":"6","author":"Lamborn","year":"2004","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0170","first-page":"1238","article-title":"Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort","volume":"50","author":"Pollack","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2017.10.041_b0175","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2017.10.041_b0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11060-010-0297-3","article-title":"Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group","volume":"99","author":"Pollack","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0185","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1158\/1078-0432.CCR-10-0438","article-title":"A distinct spectrum of copy number aberrations in pediatric high-grade gliomas","volume":"16","author":"Bax","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jocn.2017.10.041_b0190","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11910-004-0041-5","article-title":"Low-grade glioma: supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults","volume":"4","author":"Ashby","year":"2004","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jocn.2017.10.041_b0200","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1002\/cncr.24663","article-title":"Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database","volume":"115","author":"Qaddoumi","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2017.10.041_b0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-015-1405-4","article-title":"Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers","volume":"129","author":"Korshunov","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jocn.2017.10.041_b0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11060-005-7409-5","article-title":"Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children","volume":"76","author":"Broniscer","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0215","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1200\/JCO.2002.08.141","article-title":"Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study","volume":"20","author":"Lashford","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0220","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.ejca.2006.06.021","article-title":"High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol","volume":"42","author":"Dufour","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jocn.2017.10.041_b0225","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/neuonc\/1.2.152","article-title":"The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience","volume":"1","author":"Duffner","year":"1999","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0230","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/neuonc\/not163","article-title":"Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233\/34","volume":"16","author":"Strother","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0235","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1200\/JCO.1995.13.1.112","article-title":"Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen Childrens Cancer Group","volume":"13","author":"Finlay","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0240","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJMoa012224","article-title":"Expression of p53 and prognosis in children with malignant gliomas","volume":"346","author":"Pollack","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2017.10.041_b0245","first-page":"853","article-title":"Molecular genetic analysis of giant cell glioblastomas","volume":"151","author":"Meyer-Puttlitz","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jocn.2017.10.041_b0250","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/neuonc\/not122","article-title":"Time trends in glioblastoma multiforme survival: the role of temozolomide","volume":"15","author":"Dubrow","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0255","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00381-010-1106-1","article-title":"Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution","volume":"26","author":"Chiang","year":"2010","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jocn.2017.10.041_b0260","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijrobp.2009.04.031","article-title":"Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"77","author":"Jalali","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jocn.2017.10.041_b0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fonc.2015.00028","article-title":"A multi-institutional experience in pediatric high-grade glioma","volume":"5","author":"Walston","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0270","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2147\/OTT.S33532","article-title":"Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities","volume":"6","author":"Diaz-Miqueli","year":"2013","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jocn.2017.10.041_b0275","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/14712598.2011.546341","article-title":"Nimotuzumab for pediatric diffuse intrinsic pontine gliomas","volume":"11","author":"Massimino","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jocn.2017.10.041_b0280","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/pbc.21732","article-title":"Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group","volume":"51","author":"Finlay","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jocn.2017.10.041_b0285","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2009.26.6650","article-title":"Phase I\/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma","volume":"28","author":"Stupp","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0290","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pbc.22319","article-title":"Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours","volume":"54","author":"Ardon","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jocn.2017.10.041_b0295","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.4103\/2152-7806.95417","article-title":"Importance of intraoperative magnetic resonance imaging for pediatric brain tumor surgery","volume":"3","author":"Yousaf","year":"2012","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.jocn.2017.10.041_b0300","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00381-013-2159-8","article-title":"The use of 5-aminolevulinic acid fluorescence guidance in resection of pediatric brain tumors","volume":"29","author":"Preuss","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jocn.2017.10.041_b0305","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00701-014-1997-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of brain tumors in children\u2013a technical report","volume":"156","author":"Beez","year":"2014","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.jocn.2017.10.041_b0310","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00381-012-1996-1","article-title":"Glioblastoma of the cerebellum in children: report of five cases and review of the literature","volume":"29","author":"Reddy","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jocn.2017.10.041_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2013.12.011","article-title":"Prognostic factors and survival in primary adult high grade brainstem astrocytoma: a population based study from 1973\u20132008","author":"Dey","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2017.10.041_b0320","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/cncr.24730","article-title":"Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol","volume":"116","author":"Wolff","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2017.10.041_b0325","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-014-1476-4","article-title":"The relationship between working memory and cerebral white matter volume in survivors of childhood brain tumors treated with conformal radiation therapy","author":"Jacola","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2017.10.041_b0330","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery","volume":"303","author":"Walker","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2017.10.041_b0335","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.2058","article-title":"Phase III trial of nimotuzumab for the treatment of newly diagnosed diffuse intrinsic pontine gliomas in children and adolescents","volume":"26","author":"Bode","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817311025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817311025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T01:07:33Z","timestamp":1603242453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817311025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":67,"alternative-id":["S0967586817311025"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2017.10.041","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2017.10.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}